ABVC BioPharma
ABVC
ABVC
14 hedge funds and large institutions have $1.82M invested in ABVC BioPharma in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
24% less capital invested
Capital invested by funds: $2.39M → $1.82M (-$566K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $43K
Holders
14
Holding in Top 10
–
Calls
–
Puts
$43K
Top Buyers
| 1 | +$107K | |
| 2 | +$54.9K | |
| 3 | +$39K | |
| 4 |
Jane Street
New York
|
+$29.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$19.5K |
Top Sellers
| 1 | -$59.6K | |
| 2 | -$36.3K | |
| 3 | -$2.44K | |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$456 |